{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-005896","form_type":"8-K","ticker":null,"cik":"0001697884","company_name":"VITASPRING BIOMEDICAL CO. LTD.","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.700042+00:00","generated_at":"2026-05-17T15:32:38.280991+00:00","sec_items":["4.01","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Auditor TAAD resigns; four directors/officers exit; Dr. Lai appointed CEO/CFO/Chair","bullets":["TAAD LLP resigned as independent auditor effective Aug 5, 2025; no disagreements or reportable events.","Effective Aug 7, 2025, Lin Jer-Li, Chen YenXun, Chu Pao-Chi, and Kao Cheng-Hsiang resigned from all positions.","Dr. Ssu-Chuan Lai appointed Chairperson, CEO, and CFO effective Aug 7, 2025.","Dr. Lai previously Vice General Manager at Biospring Medical, with cell manufacturing and regulatory expertise.","Resignations were not due to any disagreements with the company's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-005896","json":"https://secwatch.observer/filing/0001683168-25-005896.json","markdown":"https://secwatch.observer/filing/0001683168-25-005896.md","text":"https://secwatch.observer/filing/0001683168-25-005896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1697884/000168316825005896/0001683168-25-005896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1697884/000168316825005896/vitaspring_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:32:38.280991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c8490fc79a0bc7511d03bc0e9b79c38d688d5f8","claim":"TAAD LLP resigned as auditor of VITASPRING BIOMEDICAL CO. LTD..","evidence_excerpt":"On August 5, 2025, TAAD LLP (“TAAD”) resigned as our independent registered public accounting firm, effective immediately.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1697884/000168316825005896/0001683168-25-005896-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"resignation"},{"label":"Auditor","value":"TAAD LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}